MediFind found 6 doctor with experience in Hemoglobinopathy near Rochester, NY. Of these, 5 are Experienced and 1 are Advanced.
University Of Rochester
Francis Coyne is a Hematologist Oncology specialist and a Pediatrics provider in Rochester, New York. Dr. Coyne is rated as an Advanced provider by MediFind in the treatment of Hemoglobinopathy. His top areas of expertise are Sickle Cell Disease, Hemoglobin SC Disease, Hemoglobinopathy, and Hemoglobin E Disease.
University Of Rochester
Matthew Mcintosh is a primary care provider, practicing in Pediatrics and Internal Medicine in Rochester, New York. Dr. Mcintosh is rated as an Experienced provider by MediFind in the treatment of Hemoglobinopathy. His top areas of expertise are Sickle Cell Disease, Hemoglobinopathy, Hemoglobin E Disease, and Hemoglobin C Disease.
Suzie Noronha is a Pediatric Hematologist Oncology provider in Rochester, New York. Dr. Noronha is rated as an Experienced provider by MediFind in the treatment of Hemoglobinopathy. Her top areas of expertise are Anemia, Hemolytic Anemia, Sickle Cell Disease, and Hemoglobinopathy.
Norma Lerner is a Pediatric Hematologist Oncology provider in Rochester, New York. Dr. Lerner is rated as an Experienced provider by MediFind in the treatment of Hemoglobinopathy. Her top areas of expertise are Hemoglobinopathy, Sickle Cell Disease, Hemolytic Anemia, and Congenital Hemolytic Anemia.
University Of Rochester
Craig Mullen is a Pediatric Hematologist Oncology provider in Rochester, New York. Dr. Mullen is rated as an Experienced provider by MediFind in the treatment of Hemoglobinopathy. His top areas of expertise are Langerhans Cell Histiocytosis, Reticulohistiocytoma, Histiocytosis, Hepatoblastoma, and Bone Marrow Aspiration.
University Of Rochester
Frank Akwaa is a Hematologist Oncology specialist and a Nurse Practitioner in Rochester, New York. Mr. Akwaa is rated as an Experienced provider by MediFind in the treatment of Hemoglobinopathy. His top areas of expertise are Sickle Cell Disease, Monoclonal Gammopathy of Undetermined Significance (MGUS), Hemolytic-Uremic Syndrome, and Atypical Hemolytic Uremic Syndrome (aHUS).
Last Updated: 01/09/2026